This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Lifecodexx. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Christoph Von Kalle: Innovator in Prenatal Diagnostics
Introduction
Christoph Von Kalle is a notable inventor based in Schallstadt, Germany. He has made significant contributions to the field of prenatal diagnostics, particularly in the area of non-invasive methods for detecting chromosomal abnormalities.
Latest Patents
His most recent patent, titled "Means and methods for non-invasive diagnosis of chromosomal aneuploidy," focuses on a prenatal diagnostic method. This method involves the determination of fetal chromosomal aneuploidy using a biological sample obtained from a pregnant woman. The process includes the enrichment and quantification of selected cell-free deoxyribonucleic acid sequences that exhibit consensus nucleosome binding regions. Christoph holds 1 patent related to this innovative technique.
Career Highlights
Throughout his career, Christoph has worked with various companies, including Lifecodexx and Lifecodexx AG. His work has been instrumental in advancing prenatal diagnostic technologies, making significant impacts in the medical field.
Collaborations
Christoph has collaborated with notable professionals in his field, including Marcus Benz and Wera Hofmann. These partnerships have contributed to the development and refinement of his innovative diagnostic methods.
Conclusion
Christoph Von Kalle's contributions to prenatal diagnostics exemplify the importance of innovation in medicine. His work continues to influence the field and improve outcomes for expectant parents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile